BioSpace News Archive

Henlius Holds its 1st Overseas Scientific Advisory Board Meeting of 2023

Henlius successfully held its first Overseas Scientific Advisory Board meeting of 2023 in California, United States.

June 28, 2023
·
4 min read
Business

Boehringer Ingelheim, Fashion Institute of Technology’s DTech Lab introduce fifth piece to award-winning design collection that raises awareness of rare disease

Boehringer Ingelheim and the Fashion Institute of Technology’s DTech Lab introduce a fifth piece for The Unwearable Collection™ that showcases the devastating impact and unpredictability of generalized pustular psoriasis (GPP).

June 28, 2023
·
8 min read
Business

Ora, Inc. Appoints Nate Speicher as Chief Financial Officer

Ora, Inc. , the world’s leading Clinical Research Organization (CRO) for ophthalmology pharmaceutical and device development, announced today that Nate Speicher has been appointed Chief Financial Officer (CFO).

June 28, 2023
·
3 min read
Genetown

Alloy Therapeutics Launches Proprietary AntiClastic™ Antisense Oligonucleotide Platform to Make Potent Genetic Medicines

Alloy Therapeutics announced the launch of its novel AntiClastic™ Antisense Oligonucleotide (AntiClastic ASO) platform, which employs optimally created spatial conformation nucleic acids that further enhance the drug-like properties of antisense.

June 28, 2023
·
6 min read
Biotech Beach

Amplifica Announces First-in-Human Study Initiated

Amplifica Holdings Group, Inc. (“Amplifica”), a privately held, clinical-stage biopharmaceutical company announced the initiation of the first-in-human study of its lead candidate AMP-303.

June 28, 2023
·
2 min read
Drug Development

SELLAS Life Sciences Reports Positive Data in Completed Phase 1 Study of Galinpepimut-S Combined with Opdivo® in Advanced Malignant Pleural Mesothelioma

SELLAS Life Sciences Group, Inc. today announced topline clinical data from a Phase 1 investigator-sponsored clinical trial of its lead clinical candidate, galinpepimut-S (GPS).

June 28, 2023
·
7 min read
Genetown

Alzheimer’s Disease Mechanistic Pathways Discovered through Aitia’s Digital Twins and in silico Experiments in Causal AI to be Presented at AAIC 2023

Aitia, the leader in the application of Causal AI and Digital Twins to discover and develop new drugs, announced today that data from its Alzheimer’s Disease Digital Twins will be presented at the upcoming Alzheimer’s Association International Conference (AAIC) being held from July 16-20 in Amsterdam, Netherlands.

June 28, 2023
·
3 min read
Policy

The Vbeam 595 nm Pulsed Dye Laser, a Recognized Gold Standard for Vascular Treatment, Receives a Ground-Breaking FDA Clearance for the Treatment of Port Wine Stains and Hemangiomas in the Pediatric Population - the First Clearance of its Kind.

Candela Corporation announced that the Vbeam Family of Pulsed Dye Lasers has expanded its FDA cleared indications for use of the 595 nm wavelength to include the pediatric population for treatment of cutaneous capillary malformations, also known as port wine stains, and infantile hemangiomas / congenital hemangiomas.*

June 28, 2023
·
4 min read
ACG acquires Technical Aluminium Foil Company

Further underpinning business growth across the Middle Eastern and African markets

June 28, 2023
·
2 min read
Telo Genomics Presents Positive Data in Newly Diagnosed Multiple Myeloma Drug Resistance Study at EHA 2023

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo”) presented the results of its latest study on Friday June 09, 2023 at the European Hematology Association (EHA) 2023 annual meeting.

June 28, 2023
·
6 min read